Innovative Modeling of Puberty and Substance Use Risk

青春期和药物使用风险的创新建模

基本信息

  • 批准号:
    7222012
  • 负责人:
  • 金额:
    $ 18.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-10 至 2009-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The pubertal transition represents one of the most critical periods for the development of psychopathology and risk for later substance use due to extensive and simultaneous hormonal, physical, and social-role changes occurring during this period. Current developmental theories suggest that hormone concentrations have a direct neurochemical effect and indirect psychosocial effect on risk behavior during the pubertal transition. Assessing these direct and indirect effects will provide critical knowledge for constructing effective early substance use prevention or intervention approaches for children and adolescents. However, such knowledge is lacking due to (a) measurement error in characterization of puberty and (b) lack of adequate statistical methodology to differentiate direct and indirect effects. In response to the PA-03-044, "Risk Factors of Psychopathology Using Existing Data Sets", we propose to assess the direct and indirect effects of hormone concentrations on substance use risk during the pubertal transitional period using an exceptional dataset from an NIH-funded study (5R01MH058393-03). Our novel analytical approach is a synthesis and extension of two advanced statistical techniques in order to both correct for the measurement error in puberty and to assess the direct and indirect effects based on statistical causal inference. Our aims are: (1) To assess direct and indirect effects of hormone concentrations on substance use risk during the pubertal transition using existing and new methods and to compare the results from both. (2) To develop a more accurate and informative method and a computational tool for modeling the pubertal maturation process and correcting for measurement error via a Bayesian approach. (3) To extend our generalized mediational model for assessing direct and indirect mediational effects considering latent mediator and/or latent outcome variables. The proposed work is innovative both in the field of substance use and statistical application. The study is expected to fill the gap of knowledge in early adolescent developmental substance use by examining pathways between substance use and abuse risk and the rise of hormones during the pubertal transition. It will also contribute to the statistical literature on modeling longitudinal pubertal maturational process and complex mediating mechanisms.
描述(由申请人提供):青春期过渡是精神病理学发展的最关键时期之一,也是由于在此期间发生广泛且同时发生的激素、身体和社会角色变化而导致后期物质使用风险的最关键时期之一。目前的发育理论表明,激素浓度对青春期过渡期间的危险行为具有直接的神经化学作用和间接的心理社会作用。评估这些直接和间接影响将为为儿童和青少年构建有效的早期药物使用预防或干预方法提供关键知识。然而,由于(a)青春期特征的测量误差和(b)缺乏足够的统计方法来区分直接和间接影响,因此缺乏此类知识。为了响应 PA-03-044“使用现有数据集的精神病理学风险因素”,我们建议使用 NIH 资助的研究 (5R01MH058393-03) 的特殊数据集来评估激素浓度对青春期过渡期物质使用风险的直接和间接影响。我们新颖的分析方法是两种先进统计技术的综合和扩展,以便纠正青春期的测量误差并根据统计因果推断评估直接和间接影响。我们的目标是:(1)使用现有方法和新方法评估激素浓度对青春期过渡期间物质使用风险的直接和间接影响,并比较两者的结果。 (2) 开发一种更准确、信息更丰富的方法和计算工具,用于对青春期成熟过程进行建模并通过贝叶斯方法校正测量误差。 (3)扩展我们的广义中介模型,用于评估考虑潜在中介变量和/或潜在结果变量的直接和间接中介效应。拟议的工作在物质使用和统计应用领域均具有创新性。该研究预计将通过检查药物使用和滥用风险之间的途径以及青春期过渡期间激素的上升来填补青少年早期发育药物使用的知识空白。它还将为纵向青春期成熟过程和复杂中介机制建模的统计文献做出贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BIN HUANG其他文献

BIN HUANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BIN HUANG', 18)}}的其他基金

Inform Shared Decision-making with Advanced Bayesian Causal Inference to Improve Quality of Pediatric Rheumatology Care
通过高级贝叶斯因果推理为共享决策提供信息,以提高儿科风湿病护理的质量
  • 批准号:
    10646649
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
IGF::OT::IGF EVALUATING FEASIBILITY OF AND POTENTIAL BIASES IN SUPPLEMENTING CANCER REGISTRY DATA USING EXTERNAL SOURCES
IGF::OT::IGF 评估使用外部来源补充癌症登记数据的可行性和潜在偏差
  • 批准号:
    9161902
  • 财政年份:
    2015
  • 资助金额:
    $ 18.75万
  • 项目类别:
Innovative Modeling of Puberty and Substance Use Risk
青春期和药物使用风险的创新建模
  • 批准号:
    7847036
  • 财政年份:
    2006
  • 资助金额:
    $ 18.75万
  • 项目类别:
Innovative Modeling of Puberty and Substance Use Risk
青春期和药物使用风险的创新建模
  • 批准号:
    7342873
  • 财政年份:
    2006
  • 资助金额:
    $ 18.75万
  • 项目类别:
Innovative Modeling of Puberty and Substance Use Risk
青春期和药物使用风险的创新建模
  • 批准号:
    7563938
  • 财政年份:
    2006
  • 资助金额:
    $ 18.75万
  • 项目类别:
Innovative Modeling of Puberty and Substance Use Risk
青春期和药物使用风险的创新建模
  • 批准号:
    7102976
  • 财政年份:
    2006
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了